abstract |
It has been demonstrated that antidiabetic thiazolidine and oxazolidine derivatives (glitazones) exhibit novel effects on apoptosis of cardiomyocytes. These substances are capable of greatly decreasing apoptosis by a pathway that is not Caspase 3 dependent. Addition of IGF1 to the treatment further prevents apoptosis. Glitazones alone or glitazones plus IGF1 should be administered at the beginning of a myocardial infarction and continued through the recuperation period to reduce morbidity and prevent unfavorable remodeling of the myocardium. |